GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Getinge AB (FRA:GTN) » Definitions » Cyclically Adjusted Revenue per Share

Getinge AB (FRA:GTN) Cyclically Adjusted Revenue per Share : €11.58 (As of Mar. 2025)


View and export this data going back to . Start your Free Trial

What is Getinge AB Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Getinge AB's adjusted revenue per share for the three months ended in Mar. 2025 was €2.789. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €11.58 for the trailing ten years ended in Mar. 2025.

During the past 12 months, Getinge AB's average Cyclically Adjusted Revenue Growth Rate was -0.70% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 4.70% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 4.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Getinge AB was 6.20% per year. The lowest was 1.30% per year. And the median was 4.70% per year.

As of today (2025-05-23), Getinge AB's current stock price is €17.48. Getinge AB's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was €11.58. Getinge AB's Cyclically Adjusted PS Ratio of today is 1.51.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Getinge AB was 3.94. The lowest was 0.77. And the median was 1.68.


Getinge AB Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Getinge AB's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Getinge AB Cyclically Adjusted Revenue per Share Chart

Getinge AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.43 10.53 10.88 11.26 10.80

Getinge AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.80 10.87 10.85 10.80 11.58

Competitive Comparison of Getinge AB's Cyclically Adjusted Revenue per Share

For the Medical Devices subindustry, Getinge AB's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Getinge AB's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Getinge AB's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Getinge AB's Cyclically Adjusted PS Ratio falls into.


;
;

Getinge AB Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Getinge AB's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=2.789/132.8245*132.8245
=2.789

Current CPI (Mar. 2025) = 132.8245.

Getinge AB Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 3.062 99.995 4.067
201509 2.934 100.228 3.888
201512 4.026 100.276 5.333
201603 2.707 100.751 3.569
201606 2.945 101.019 3.872
201609 2.993 101.138 3.931
201612 0.825 102.022 1.074
201703 2.087 102.022 2.717
201706 2.277 102.752 2.943
201709 2.097 103.279 2.697
201712 2.725 103.793 3.487
201803 1.759 103.962 2.247
201806 2.047 104.875 2.593
201809 2.000 105.679 2.514
201812 2.820 105.912 3.537
201903 1.940 105.886 2.434
201906 2.168 106.742 2.698
201909 2.141 107.214 2.652
201912 2.977 107.766 3.669
202003 2.036 106.563 2.538
202006 2.441 107.498 3.016
202009 2.808 107.635 3.465
202012 3.190 108.296 3.913
202103 2.227 108.360 2.730
202106 2.391 108.928 2.916
202109 2.277 110.338 2.741
202112 2.855 112.486 3.371
202203 2.155 114.825 2.493
202206 2.309 118.384 2.591
202209 2.359 122.296 2.562
202212 2.838 126.365 2.983
202303 2.337 127.042 2.443
202306 2.258 129.407 2.318
202309 2.361 130.224 2.408
202312 3.250 131.912 3.272
202403 2.437 132.205 2.448
202406 2.701 132.716 2.703
202409 2.545 132.304 2.555
202412 3.534 132.987 3.530
202503 2.789 132.825 2.789

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Getinge AB  (FRA:GTN) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Getinge AB's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=17.48/11.58
=1.51

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Getinge AB was 3.94. The lowest was 0.77. And the median was 1.68.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Getinge AB Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Getinge AB's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Getinge AB Business Description

Industry
Traded in Other Exchanges
Address
Lindholmspiren 7A, P.O. Box 8861, Gothenburg, SWE, SE-417 56
Getinge, headquartered in Gothenburg, Sweden, manufactures a wide range of products for use in acute care, surgical, and life sciences in the hospital, pharmaceutical, and research settings. The company reports in three segments: acute care therapies (52% of revenue), surgical workflows (34%), and life sciences (14%). Product areas include ventilators, surgical stents, life support systems, sterilizers, surgical tables, and sterile transfer systems. Getinge derives revenue from a broad geographic footprint, with the Americas accounting for 45% of sales (U.S. 33% of sales), Asia-Pacific 25%, and Europe, Middle East, and Africa the remaining 30%.